Zusammenfassung
Tumoren des disseminierten/diffusen neuroendokrinen Systems sind durch einen gemeinsamen Phänotyp gekennzeichnet. In ihrer Biologie unterscheiden sich neuroendokrine Tumoren (NET) jedoch bzgl. Morphologie, endokrinologischer Symptomatik und Ursprungsorgan. Die WHO-Klassifikation trägt diesen Unterschieden Rechnung und klassifiziert NET nach einem einheitlichen Vorgehen, wobei die Parameter Größe und Invasionstiefe je nach Ursprungsorgan variieren. Um die Nomenklatur weiter zu vereinheitlichen, wurde vor kurzem von der „European Neuroendocrine Tumor Society“ (ENETS) der Vorschlag einer TNM-Stadien-Einteilung und Graduierung gastroenteropankreatischer NET vorgelegt.
Abstract
Tumors of the disseminated/diffuse neuroendocrine system (NET) are characterized by a common phenotype. However, the biology varies according to histomorphology, endocrine symptoms and organ of origin. The WHO classification takes these differences into account and uses a common framework, where the parameters size and extent of invasion vary according to the organ of origin. In order to achieve a further standardization of reporting the European Neuroendocrine Tumor Society (ENETS) recently proposed a tumor-node-metastasis (TNM) staging and grading system for gastro-entero-pancreatic NET.
This is a preview of subscription content,
to check access.

Literatur
Anlauf M et al (2007) Hereditary neuroendocrine tumors of the gastroenteropancreatic system. Virchows Arch 451 [suppl 1]:S29–S38
Anlauf M et al (2006) Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features. World J Gastroenterol 12(34):5440–5446
Burke AP et al (1997) Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases. Cancer 79(6):1086–1093
Capella C et al (1995) Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch 425(6):547–560
De Herder WW, O’Toole D et al (2006) ENETS consensus guidelines for the management of patients with digestive neuroendocrine tumors. Part 1 – Stomach, Duodenum and Pancreas. Neuroendocrinology 84(1)
De Herder WW, O’Toole D et al (2008) ENETS consensus guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumors. Part 2 – midgut and hindgut tumors. Neuroendocrinology 87(1)
DeLellis R et al (2004) Pathology and genetics of tumours of endocrine organs. World Health Organization classification of tumours. IARC Press, Lyon
Gosset A, Masson P (1914) Tumeurs endocrines de l’appendice. Presse Med 25:237–240
Grimelius L, Hultquist GT, Stenkvist B (1975) Cytological differentiation of asymptomatic pancreatic islet cell tumours in autopsy material. Virchows Arch A Pathol Anat Histol 365(4):275–288
Heitz P, Komminoth P et al (2004) Tumours of the endocrine pankreas. In: DeLellis R, Heintz P, Lloyd R, Eng C (eds) Pathology and genetics of tumours of endocrine organs. WHO classification of tumours, chapter 4. IARC Press, Lyon
Hemminki K, Li X (2001) Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden. Cancer 92(8):2204–2210
Jensen RT et al (2006) Well-differentiated duodenal tumor/carcinoma (excluding gastrinomas). Neuroendocrinology 84(3):165–172
Kimura W, Kuroda A, Morioka Y (1991) Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases. Dig Dis Sci 36(7):933–942
Marshall JB, Bodnarchuk G (1993) Carcinoid tumors of the gut. Our experience over three decades and review of the literature. J Clin Gastroenterol 16(2):123–129
Modlin IM, Lye KD, Kidd M (2003) A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97(4):934–959
Modlin IM et al (2008) Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 9(1):61–72
Moldow RE, Connelly RR (1968) Epidemiology of pancreatic cancer in connecticut. Gastroenterology 55(6):677–686
Oberndorfer S (1907) Karzinoide Tumoren des Dünndarms. Frankf Z Pathol 1:426–432
Peck JJ et al (1983) Carcinoid tumors of the ileum. Am J Surg 146(1):124–132
Ramage JK et al (2008) Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated colon and rectum tumour/carcinoma. Neuroendocrinology 87(1):31–39
Rindi G et al (1999) ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology 116(3):532–542
Rindi G et al (2006) TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449(4):395–401
Rindi G et al (2007) TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 451(4):757–762
Schmitt AM et al (2007) WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors. Am J Surg Pathol 31(11):1677–1682
Service FJ et al (1976) Insulinoma: clinical and diagnostic features of 60 consecutive cases. Mayo Clin Proc 51(7):417–429
Stinner B et al (1996) Surgical management for carcinoid tumors of small bowel, appendix, colon and rectum. World J Surg 20(2):183–188
Williams ED, Sandler M (1963) The classification of carcinoid tumours. Lancet 1(7275):238–239
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Perren, A., Schmitt, A., Komminoth, P. et al. Klassifikation gastroenteropankreatischer neuroendokriner Tumoren. Radiologe 49, 198–205 (2009). https://doi.org/10.1007/s00117-008-1781-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00117-008-1781-z